Tuesday PR's are not the problem. Which way BMSN goes without approval of Hema or dCell was obvious. Imo won't change this year cause i don't see any approval this year. But it's up to CEO Koos to prove me wrong. Days left 275.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.